Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Breast Cancer Research and Treatment

Issue Special Issue 1/2008

Optimizing breast cancer patient care today and tomorrow: implications for clinicians

Content (7 Articles)

Optimizing Breast Cancer Patient

Editorial

Matti Aapro

Optimizing Breast Cancer Patient

Treatment decision-making in breast cancer: the patient–doctor relationship

L. J. Fallowfield

Optimizing Breast Cancer Patient

Improving decision-making in early breast cancer: who to treat and how?

Antonio Llombart-Cussac

Optimizing Breast Cancer Patient

Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer

Rowan T. Chlebowski

Optimizing Breast Cancer Patient

Are all aromatase inhibitors alike?

Kimberly L. Blackwell

Optimizing Breast Cancer Patient

Extending the benefits of adjuvant therapy in early HR+ breast cancer

Paul E. Goss

Optimizing Breast Cancer Patient

Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer

Joseph Gligorov, Jean-Pierre Lotz

Dec 08
Issue: 3/2008
Jan 09
Issue: 1/2009

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits